208 related articles for article (PubMed ID: 32162657)
1. Antiretroviral Therapy and Detection of High-grade Cervical Intraepithelial Neoplasia (CIN2+) at Post-CIN Management Follow-up Among Women Living With Human Immunodeficiency Virus: A Systematic Review and Meta-Analysis.
Atemnkeng N; Aji AD; de Sanjose S; Mayaud P; Kelly H
Clin Infect Dis; 2020 Dec; 71(10):e540-e548. PubMed ID: 32162657
[TBL] [Abstract][Full Text] [Related]
2. Association of antiretroviral therapy with high-risk human papillomavirus, cervical intraepithelial neoplasia, and invasive cervical cancer in women living with HIV: a systematic review and meta-analysis.
Kelly H; Weiss HA; Benavente Y; de Sanjose S; Mayaud P;
Lancet HIV; 2018 Jan; 5(1):e45-e58. PubMed ID: 29107561
[TBL] [Abstract][Full Text] [Related]
3. Association of antiretroviral therapy with anal high-risk human papillomavirus, anal intraepithelial neoplasia, and anal cancer in people living with HIV: a systematic review and meta-analysis.
Kelly H; Chikandiwa A; Alemany Vilches L; Palefsky JM; de Sanjose S; Mayaud P
Lancet HIV; 2020 Apr; 7(4):e262-e278. PubMed ID: 32109408
[TBL] [Abstract][Full Text] [Related]
4. Associations of human gene EPB41L3 DNA methylation and cervical intraepithelial neoplasia in women living with HIV-1 in Africa.
Kelly HA; Chikandiwa A; Warman R; Segondy M; Sawadogo B; Vasiljevic N; Didelot MN; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P; Lorincz A
AIDS; 2018 Sep; 32(15):2227-2236. PubMed ID: 30005021
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy.
Kelly HA; Sawadogo B; Chikandiwa A; Segondy M; Gilham C; Lompo O; Omar T; Didelot MN; Nagot N; Meda N; Weiss HA; Delany-Moretlwe S; Mayaud P;
AIDS; 2017 Jan; 31(2):273-285. PubMed ID: 27755107
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of human papillomavirus (HPV) 16 and HPV18 viral loads for the detection of high-grade cervical intraepithelial neoplasia (CIN2+) in a cohort of African women living with HIV.
Segondy M; Ngou J; Kelly H; Omar T; Goumbri-Lompo O; Doutre S; Mayaud P; Didelot MN
J Clin Virol; 2018; 99-100():79-83. PubMed ID: 29353074
[TBL] [Abstract][Full Text] [Related]
7. Cervical neoplastic lesions in relation to CD4 T-lymphocyte counts and antiretroviral therapy among women with clinical stage 1 HIV in Yunnan, China.
Zhang DY; Chen W; Zhang HY; Lv SQ; Lu XN; Tao YP; Zhang M; Liu JF; Yang M; Qiao YL; Braithwaite D
Kaohsiung J Med Sci; 2020 Jun; 36(6):450-459. PubMed ID: 31913555
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic accuracy of cervical cancer screening and screening-triage strategies among women living with HIV-1 in Burkina Faso and South Africa: A cohort study.
Kelly HA; Chikandiwa A; Sawadogo B; Gilham C; Michelow P; Lompo OG; Omar T; Zan S; Magooa P; Segondy M; Nagot N; Meda N; Delany-Moretlwe S; Mayaud P;
PLoS Med; 2021 Mar; 18(3):e1003528. PubMed ID: 33661957
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+/CIN3+) among women living with HIV: A systematic review and meta-analysis.
Kelly H; Jaafar I; Chung M; Michelow P; Greene S; Strickler H; Xie X; Schiffman M; Broutet N; Mayaud P; Dalal S; Arbyn M; de Sanjosé S
EClinicalMedicine; 2022 Nov; 53():101645. PubMed ID: 36187721
[TBL] [Abstract][Full Text] [Related]
10. Multiple High-Risk HPV Types Contribute to Cervical Dysplasia in Ugandan Women Living With HIV on Antiretroviral Therapy.
Nakisige C; Adams SV; Namirembe C; Okoche L; Ferrenberg J; Towlerton A; Larsen A; Orem J; Casper C; Frenkel L; Uldrick TS
J Acquir Immune Defic Syndr; 2022 Jul; 90(3):333-342. PubMed ID: 35195571
[TBL] [Abstract][Full Text] [Related]
11. Immunodeficiency and the risk of cervical intraepithelial neoplasia 2/3 and cervical cancer: A nested case-control study in the Swiss HIV cohort study.
Clifford GM; Franceschi S; Keiser O; Schöni-Affolter F; Lise M; Dehler S; Levi F; Mousavi M; Bouchardy C; Wolfensberger A; Darling KE; Staehelin C; Bertisch B; Kuenzli E; Bernasconi E; Pawlita M; Egger M;
Int J Cancer; 2016 Apr; 138(7):1732-40. PubMed ID: 26537763
[TBL] [Abstract][Full Text] [Related]
12. Risk factors, diagnosis and prognosis of cervical intraepithelial neoplasia among HIV-infected women.
Lehtovirta P; Paavonen J; Heikinheimo O
Int J STD AIDS; 2008 Jan; 19(1):37-41. PubMed ID: 18275645
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus vaccination in women undergoing excisional treatment for cervical intraepithelial neoplasia and subsequent risk of recurrence: A systematic review and meta-analysis.
Eriksen DO; Jensen PT; Schroll JB; Hammer A
Acta Obstet Gynecol Scand; 2022 Jun; 101(6):597-607. PubMed ID: 35470865
[TBL] [Abstract][Full Text] [Related]
14. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
15. Human papillomavirus infection and associated factors for cervical intraepithelial neoplasia in women living with HIV in China: a cross-sectional study.
Wang Q; Ma X; Zhang X; Ong JJ; Jing J; Zhang L; Wang LH
Sex Transm Infect; 2019 Mar; 95(2):140-144. PubMed ID: 30337414
[TBL] [Abstract][Full Text] [Related]
16. Suppressive antiretroviral therapy associates with effective treatment of high-grade cervical intraepithelial neoplasia.
Carlander C; Wagner P; van Beirs A; Yilmaz A; Elfgren K; Dillner J; Sönnerborg A; Sparén P
AIDS; 2018 Jul; 32(11):1475-1484. PubMed ID: 29746299
[TBL] [Abstract][Full Text] [Related]
17. Incidence of cervical precancers among HIV-seropositive women.
Massad LS; Xie X; D'Souza G; Darragh TM; Minkoff H; Wright R; Colie C; Sanchez-Keeland L; Strickler HD
Am J Obstet Gynecol; 2015 May; 212(5):606.e1-8. PubMed ID: 25499260
[TBL] [Abstract][Full Text] [Related]
18. The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis.
Loopik DL; Bentley HA; Eijgenraam MN; IntHout J; Bekkers RLM; Bentley JR
J Low Genit Tract Dis; 2021 Jul; 25(3):221-231. PubMed ID: 34176914
[TBL] [Abstract][Full Text] [Related]
19. Persistence and clearance of high-risk human papillomavirus and cervical dysplasia at 1 year in women living with human immunodeficiency virus: a prospective cohort study.
Luckett R; Painter H; Hacker MR; Simon B; Seiphetlheng A; Erlinger A; Eakin C; Moyo S; Kyokunda LT; Esselen K; Feldman S; Morroni C; Ramogola-Masire D
BJOG; 2021 Nov; 128(12):1986-1996. PubMed ID: 34008294
[TBL] [Abstract][Full Text] [Related]
20. HIV-Infected Women with Low-Grade Squamous Intraepithelial Lesion on Cervical Cytology Have Higher Risk of Underlying High-Grade Cervical Intraepithelial Neoplasia.
Sakdadech N; Muangmool T; Srisomboon J
Int J Environ Res Public Health; 2021 Sep; 18(19):. PubMed ID: 34639509
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]